Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data

Archives of Cardiovascular Diseases

Volumn 104, Issue 2, 2011, Pages 115-124

  Charlemagne, Agnès ^a   Blacher, Jacques ^b   Cohen, Ariel ^c   Collet, Jean Philippe ^d   Diévart, François ^e   De Groote, Pascal ^f   Hanon, Olivier ^g   Leenhardt, Antoine ^h   Pinel, Jean François ⁱ   Pisica Donose, George ^j   Le Heuzey, Jean Yves ^k  

^a CEMKA EVAL   (France)

^b HÔTEL DIEU   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Clinique Villette   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^j BRISTOL MYERS SQUIBB   (United States)

^k HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

Atrial fibrillation; Comorbidity; Epidemiology; Hospitalization; Incidence; Prevalence

Indexed keywords

COMORBIDITY; COST OF ILLNESS; EPIDEMIC; FRANCE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PREVALENCE; REVIEW;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; SEX DISTRIBUTION; TIME FACTORS;

EID: 79952902268     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.11.012     Document Type: Review

References (50)

1. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
2. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
3. Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-84.
4. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469-73.
5. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
6. Le Heuzey JY, Paziaud O. Atrial fibrillation. Rev Prat 2003;53:1805-12. (Pubitemid 37432493)
7. DeWilde S, Carey IM, Emmas C, et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006;92:1064-70. (Pubitemid 44131331)
8. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001;86:284-8.
9. Bajpai A, Savelieva I, Camm AJ. Epidemiology and economic burden of atrial fibrillation. US Cardiovascular Dis Touch Briefings 2007; http://www.touchbriefings.com/pdf/2777/bajpai.pdf.
10. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
11. Le Heuzey JY, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004;147:121-6. (Pubitemid 38037407)
12. Guize L, Thomas F, Bean K, et al. Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up. Bull Acad Natl Med 2007;191:791-803 [discussion 03-5].
13. Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999;99:3028-35. (Pubitemid 29270433)
14. Kerr CR, Humphries KH, Talajic M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005;149:489-96. (Pubitemid 40585413)
15. Lehto M, Kala R. Persistent atrial fibrillation: a population based study of patients with their first cardioversion. Int J Cardiol 2003;92:145-50. (Pubitemid 37540384)
16. Mabo P, Pavin D, Leclercq C. Epidemiology and etiology of atrial fibrillation. Rev Prat 2002;52:1295-300.
17. Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41. (Pubitemid 24239044)
18. Lake FR, Cullen KJ, de Klerk NH, et al. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989;19:321-6. (Pubitemid 19263526)
19. Phillips SJ, Whisnant JP, O'Fallon WM, et al. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-59. (Pubitemid 20124303)
20. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
21. Lip GY, Golding DJ, Nazir M, et al. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract 1997;47:285-9. (Pubitemid 27208108)
22. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-12. (Pubitemid 46722325)
23. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart 2001;86:516-21. (Pubitemid 32999861)
24. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
25. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
26. Psaty BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-61. (Pubitemid 27425856)
27. Flaker GC, Belew K, Beckman K, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657-63.
28. Frykman V, Frick M, Jensen-Urstad M, et al. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med 2001;250:390-7. (Pubitemid 32989593)
29. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
30. Crijns HJ, Tjeerdsma G, de Kam PJ, et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000;21:1238-45. (Pubitemid 30487771)
31. O'Hara GE, Charbonneau L, Chandler M, et al. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database). Am J Cardiol 2005;96:815-21. (Pubitemid 41317657)
32. Sudlow M, Thomson R, Thwaites B, et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-71. (Pubitemid 28458530)
33. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7. (Pubitemid 39552671)
34. van Walraven C, Hart RG, Wells GA, et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 2003;163:936-43. (Pubitemid 36519739)
35. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
36. Rietbrock S, Heeley E, Plumb J, et al. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age > 75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J 2008;156:57-64.
37. Wolf PA, Dawber TR, Thomas Jr HE, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978;28:973-7. (Pubitemid 8401525)
38. Hart RG, Pearce LA. Current status of stroke risk stratification in patients with atrial fibrillation. Stroke 2009;40:2607-10.
39. Milliken JA. Atrial fibrillation and embolism. Can Med Assoc J 1983;128:1370-2. (Pubitemid 13063982)
40. Miyasaka Y, Barnes ME, Gersh BJ, et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J 2006;27:936-41.
41. Nieuwlaat R, Eurlings LW, Cleland JG, et al. Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. J Am Coll Cardiol 2009;53:1690-8.
42. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5. (Pubitemid 36736633)
43. Savelieva I, Paquette M, Dorian P, et al. Quality of life in patients with silent atrial fibrillation. Heart 2001;85:216-7. (Pubitemid 32973598)
44. Dorian P, Jung W, Newman D, et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000;36:1303-9.
45. Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI102-10.
46. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703. (Pubitemid 28435256)
47. Friberg L, Hammar N, Pettersson H, et al. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J 2007;28:2346-53. (Pubitemid 47537782)
48. Pavillon G, Laurent F. Certification et codification des causes médicales de décès. BEH 2003;30-31:134-8.
49. Khairallah F, Ezzedine R, Ganz LI, et al. Epidemiology and determinants of outcome of admissions for atrial fibrillation in the United States from 1996 to 2001. Am J Cardiol 2004;94:500-4.
50. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373:739-45.